Oct 072014

I was reading a little about Biogen’s new drug anti-lingo-1 / BIIB033. While this is too early to call as the drug is in Phase 2 clinical trials I am sure we will see it on the market. I have to agree with this article that it is not specified how they are testing for remyelination. If there was a side benefit I would hope that the Anti-LINGO-1 would help with my tremor because there is a noted increase in LINGO-1 cells with people with essential tremor. I will take hopeful stance as this does appear to be promising candidate for remyelination.

As an addendum I did some additional searches and the MRI technique to measure remyelination does seem interesting. You can view some images in the presentation here along with some additional data about the drug.